NASDAQ: AVTE - Aerovate Therapeutics, Inc.

Yield per half year: +64.81%
Sector: Healthcare

Current price
25.65 $
Average price
8.08 $ -68.49%

Price based on EPS
14.52 $ -43.39%
0/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 14.52 $
Current price = 25.65 $ (difference = -43.39%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -3.82 $
Current price = 25.65 $ (difference = -114.91%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -2.48 $
Current price = 25.65 $ (difference = -109.69%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription